Regulatory submission to expand the label for Igalmi use in the outpatient setting is expected in the first quarter of 2026. At-home administration of dexmedetomidine sublingual film as a treatment ...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...

Gray Media, Inc. (NYSE:GTN) reported mixed results for the second quarter on Friday. The company posted a quarterly loss of 42 cents per share, versus the analyst consensus estimate of a loss of 36 ...

Local television broadcasting and media company Gray Television (NYSE:GTN) will be reporting earnings this Friday morning. Here’s what to expect. Gray Television beat analysts’ revenue expectations by ...

Hiroyuki Goto ventured into what appeared to be a high-risk business nearly two decades ago when, at the age of 28, he started providing rent guarantees for foreign nationals living in Japan.

In the latest trading session, Gray Media (GTN) closed at $5.14, marking a -3.2% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.07%. On the other hand, the ...

New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025 Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...

GTN shares rebounded after a strong Q2/25 pre-announcement, with early political ad revenue signaling a robust 2026 election cycle. Political ad spending is expected to surge, especially with Elon ...

Omar Darwish has joined UBS as a sales trader as part of the firm’s MENA global markets execution services team. The move sees Dubai-based Darwish leaving his previous position at fintech pioneer GTN, ...

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...

Please provide your email address to receive an email when new articles are posted on . Sublingual delivery of epinephrine achieved pharmacokinetic and pharmacodynamic results that were comparable ...